Q BioMed Featured in Proactive Investors

Q BioMed Inc. (OTCQB:QBIO), a biomedical company recently got featured in Proactive Investors.

The article talks about the company’s application to FDA for approving a new manufacturing facility for its cancer bone pain injection. The injection is called Strontium Chloride Sr89. Strontium when injected in the body acts like calcium and helps build up bone strength.

“Overall, the pain palliation market is estimated to be worth around US$300 million annually” – The article concludes.

Click here to read the full article.

Click here to connect with Q BioMed Inc. (OTCQB:QBIO) and receive an Investors Presentation. 

Source: www.proactiveinvestors.co.uk